Related Experiment Video
Updated: Jun 19, 2026

Limited Bedding and Nesting as a Model for Early-Life Adversity in Mice
Published on: July 12, 2024
Prenatal stress, glucocorticoids and the programming of adult disease
Elizabeth C Cottrell1, Jonathan R Seckl
1Endocrinology Unit, Centre for Cardiovascular Science, The Queen's Medical Research Institute, University of Edinburgh Edinburgh, Scotland.
Insights
Adverse prenatal environments, particularly excess glucocorticoids, can permanently alter offspring physiology, increasing risks for cardio-metabolic and psychiatric disorders later in life. Placental 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) protects against these effects.
Area of Science:
- Developmental biology
- Endocrinology
- Neuroscience
Background:
- Adverse prenatal environments are linked to adult cardio-metabolic, neuroendocrine, and psychiatric disorders.
- Prenatal stress or excess glucocorticoids in animal models malprogram offspring, reducing birth weight and increasing disease risk.
- Placental 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) acts as a barrier to maternal glucocorticoids during fetal development.
Purpose of the Study:
- To investigate the role of placental 11beta-HSD2 in protecting offspring from adverse prenatal environments.
- To explore the molecular mechanisms, including epigenetic changes, underlying prenatal programming.
- To understand how early life glucocorticoid exposure permanently alters glucocorticoid signaling and disease risk.
Main Methods:
- Review of clinical studies associating prenatal environment with later-life disorders.
- Analysis of animal model experiments involving prenatal stress or glucocorticoid exposure.
- Examination of the function and regulation of placental 11beta-HSD2.
- Investigation of epigenetic modifications and glucocorticoid receptor (GR) expression.
Main Results:
- Reduced placental 11beta-HSD2 in human pregnancy correlates with lower birth weight and higher blood pressure.
- Inhibition or knockout of placental 11beta-HSD2 in animal models lowers offspring birth weight by reducing fetal glucose delivery.
- Prenatal glucocorticoid exposure can lead to epigenetic changes affecting glucocorticoid signaling and increase disease susceptibility.
Conclusions:
- Placental 11beta-HSD2 is crucial for mitigating the adverse effects of maternal glucocorticoids on fetal development.
- Early life exposure to excess glucocorticoids can permanently alter glucocorticoid signaling via epigenetic mechanisms, increasing long-term disease risk.
- Understanding these programming effects is vital for preventing future health issues associated with adverse prenatal conditions.
Abstract:
Numerous clinical studies associate an adverse prenatal environment with the development of cardio-metabolic disorders and neuroendocrine dysfunction, as well as an increased risk of psychiatric diseases in later life. Experimentally, prenatal exposure to stress or excess glucocorticoids in a variety of animal models can malprogram offspring physiology, resulting in a reduction in birth weight and subsequently increasing the likelihood of disorders of cardiovascular function, glucose homeostasis, hypothalamic-pituitary-adrenal (HPA) axis activity and anxiety-related behaviours in adulthood. During fetal development, placental 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) provides a barrier to maternal glucocorticoids. Reduced placental 11beta-HSD2 in human pregnancy correlates with lower birth weight and higher blood pressure in later life. Similarly, in animal models, inhibition or knockout of placental 11beta-HSD2 lowers offspring birth weight, in part by reducing glucose delivery to the developing fetus in late gestation. Molecular mechanisms thought to underlie the programming effects of early life stress and glucocorticoids include epigenetic changes in target chromatin, notably affecting tissue-specific expression of the intracellular glucocorticoid receptor (GR). As such, excess glucocorticoids in early life can permanently alter tissue glucocorticoid signalling, effects which may have short-term adaptive benefits but increase the risk of later disease.
More Related Videos
Related Concept Videos
Hypothalamic-Pituitary Axis
Psychoneuroimmunology: Diabetes and Cancer
Physiological Foundation of Stress
Role of the Sympathetic Nervous System
Adrenaline triggers the...
Cushing Syndrome II: Pathophysiology
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...

